C4 Therapeutics (CCCC) Profit After Tax (2019 - 2025)
Historic Profit After Tax for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to -$32.2 million.
- C4 Therapeutics' Profit After Tax fell 3040.62% to -$32.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$119.1 million, marking a year-over-year decrease of 1286.87%. This contributed to the annual value of -$105.3 million for FY2024, which is 2051.62% up from last year.
- Latest data reveals that C4 Therapeutics reported Profit After Tax of -$32.2 million as of Q3 2025, which was down 3040.62% from -$26.0 million recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Profit After Tax ranged from a high of -$15.7 million in Q4 2021 and a low of -$37.2 million during Q4 2022
- Moreover, its 5-year median value for Profit After Tax was -$27.4 million (2022), whereas its average is -$28.1 million.
- In the last 5 years, C4 Therapeutics' Profit After Tax crashed by 13752.07% in 2022 and then soared by 5068.2% in 2024.
- Over the past 5 years, C4 Therapeutics' Profit After Tax (Quarter) stood at -$15.7 million in 2021, then tumbled by 137.52% to -$37.2 million in 2022, then increased by 6.58% to -$34.8 million in 2023, then rose by 0.54% to -$34.6 million in 2024, then increased by 6.96% to -$32.2 million in 2025.
- Its last three reported values are -$32.2 million in Q3 2025, -$26.0 million for Q2 2025, and -$26.3 million during Q1 2025.